The cardiac (pro)renin receptor is primarily expressed in myocyte transverse tubules and is increased in experimental diabetic cardiomyopathy

Journal of Hypertension

Volumn 29, Issue 6, 2011, Pages 1175-1184

  Connelly, Kim A ^a,b,f   Advani, Andrew ^a   Kim, Sandra ^c   Advani, Suzanne L ^a   Zhang, Michael ^b   White, Kathryn E ^d   Kim, Young M ^a   Parker, Colleen ^a   Thai, Kerri ^a   Krum, Henry ^e   Kelly, Darren J ^b   Gilbert, Richard E ^a,b,f  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF TORONTO   (Canada)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e MONASH UNIVERSITY   (Australia)

^f ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

diabetes; diastolic dysfunction; direct renin inhibition; pro(renin) receptor

Indexed keywords

ALISKIREN; MESSENGER RNA; PRORENIN RECEPTOR; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; RYANODINE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL VACUOLE; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; DIASTOLIC DYSFUNCTION; FIBROSING ALVEOLITIS; GENE EXPRESSION; GENE SILENCING; HEART FUNCTION; HEART HEMODYNAMICS; HEART HYPERTROPHY; HEART MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN LOCALIZATION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SARCOPLASMIC RETICULUM; TRANSMISSION ELECTRON MICROSCOPY; TRANSVERSE TUBULAR SYSTEM;

EID: 79955604483     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283462674     Document Type: Article

References (49)

1. Nguyen G, Delarue F, Burckle C, Bouzhir L, Giller T, Sraer JD. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 2002; 109:1417-1427. (Pubitemid 34596167)
2. Tang M, Zhang W, Lin H, Jiang H, Dai H, Zhang Y. High glucose promotes the production of collagen types I and III by cardiac fibroblasts through a pathway dependent on extracellular-signal-regulated kinase 1/2. Mol Cell Biochem 2007; 301:109-114. (Pubitemid 46895150)
3. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007; 292:C82-C97. (Pubitemid 46127306)
4. Frustaci A, Kajstura J, Chimenti C, Jakoniuk I, Leri A, Maseri A, et al. Myocardial cell death in human diabetes. Circ Res 2000; 87:1123-1132.
5. Yoon YS, Uchida S, Masuo O, Cejna M, Park JS, Gwon HC, et al. Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor. Circulation 2005; 111:2073-2085. (Pubitemid 40577902)
6. Campbell DJ. Critical review of prorenin and (pro)renin receptor research. Hypertension 2008; 51:1259-1264. (Pubitemid 351555933)
7. Mercure C, Prescott G, Lacombe MJ, Silversides DW, Reudelhuber TL. Chronic increases in circulating prorenin are not associated with renal or cardiac pathologies. Hypertension 2009; 53:1062-1069.
8. Advani A, Kelly DJ, Cox AJ, White KE, Advani SL, Thai K, et al. The (Pro)renin receptor: site-specific and functional linkage to the vacuolar H\+- ATPase in the kidney. Hypertension 2009; 54:261-269.
9. Kelly DJ, Zhang Y, Moe G, Naik G, Gilbert RE. Aliskiren, a novel renin inhibitor, is renoprotective in a model of advanced diabetic nephropathy in rats. Diabetologia 2007; 50:2398-2404. (Pubitemid 47512400)
10. Connelly KA, Kelly DJ, Zhang Y, Prior DL, Martin J, Cox AJ, et al. Functional, structural and molecular aspects of diastolic heart failure in the diabetic (mRen-2)27 rat. Cardiovasc Res 2007; 76:280-291. (Pubitemid 350214455)
11. Connelly KA, Prior DL, Kelly DJ, Feneley MP, Krum H, Gilbert RE. Loadsensitive measures may overestimate global systolic function in the presence of left ventricular hypertrophy: a comparison with loadinsensitive measures. Am J Physiol Heart Circ Physiol 2006; 290:H1699-H1705.
12. Georgakopoulos D, Mitzner WA, Chen CH, Byrne BJ, Millar HD, Hare JM, et al. In vivo murine left ventricular pressure-volume relations by miniaturized conductance micromanometry. Am J Physiol 1998; 274:H1416-H1422.
13. Yang B, Larson DF, Watson R. Age-related left ventricular function in the mouse: analysis based on in vivo pressure-volume relationships. Am J Physiol 1999; 277:H1906-H1913.
14. Pacher P, Mabley JG, Liaudet L, Evgenov OV, Marton A, Hasko G, et al. Left ventricular pressure-volume relationship in a rat model of advanced agingassociated heart failure. Am J Physiol Heart Circ Physiol 2004; 287:H2132-H2137. (Pubitemid 39430753)
15. Sarnoff SJ, Berglund E. Ventricular function. I. Starling's law of the heart studied by means of simultaneous right and left ventricular function curves in the dog. Circulation 1954; 9:706-718.
16. Li Q, Lau A, Morris TJ, Guo L, Fordyce CB, Stanley EF. A syntaxin 1, Galpha(o), and N-type calcium channel complex at a presynaptic nerve terminal: analysis by quantitative immunocolocalization. J Neurosci 2004; 24:4070-4081. (Pubitemid 38544233)
17. Kelly DJ, Zhang Y, Hepper C, Gow RM, Jaworski K, Kemp BE, et al. Protein kinase C beta inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension. Diabetes 2003; 52:512-518. (Pubitemid 36173211)
18. Kai H, Muraishi A, Sugiu Y, Nishi H, Seki Y, Kuwahara F, et al. Expression of proto-oncogenes and gene mutation of sarcomeric proteins in patients with hypertrophic cardiomyopathy. Circ Res 1998; 83:594-601. (Pubitemid 28427742)
19. Bhuyan BK, Loughman BE, Fraser TJ, Day KJ. Comparison of different methods of determining cell viability after exposure to cytotoxic compounds. Exp Cell Res 1976; 97:275-280.
20. Petrovic MM, Vales K, Putnikovic B, Djulejic V, Mitrovic DM. Ryanodine receptors, voltage-gated calcium channels and their relationship with protein kinase A in the myocardium. Physiol Res 2008; 57:141-149.
21. Connelly KA, Kelly DJ, Zhang Y, Prior DL, Advani A, Cox AJ, et al. Inhibition of protein kinase C-beta by ruboxistaurin preserves cardiac function and reduces extracellular matrix production in diabetic cardiomyopathy. Circ Heart Fail 2009; 2:129-137.
22. Burckle C, Bader M. Prorenin and its ancient receptor. Hypertension 2006; 48:549-551. (Pubitemid 44843851)
23. Strausberg RL, Feingold EA, Grouse LH, Derge JG, Klausner RD, Collins FS, et al. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci USA 2002; 99:16899-16903. (Pubitemid 36034070)
24. Reudelhuber TL. Prorenin, renin, and their receptor: moving targets. Hypertension 2010; 55:1071-1074.
25. Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Nakagawa T, Nishiyama A, et al. Contribution of nonproteolytically activated prorenin in glomeruli to hypertensive renal damage. J Am Soc Nephrol 2006; 17:2495-2503. (Pubitemid 44300965)
26. Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Suzuki F, Nakagawa T, et al. Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension 2006; 47:894-900. (Pubitemid 44297561)
27. Hayashi T, Martone ME, Yu Z, Thor A, Doi M, Holst MJ, et al. Threedimensional electron microscopy reveals new details of membrane systems for Ca2\+ signaling in the heart. J Cell Sci 2009; 122:1005-1013.
28. Camello C, Pariente JA, Salido GM, Camello PJ. Role of proton gradients and vacuola H(\+)-ATPases in the refilling of intracellular calcium stores in exocrine cells. Curr Biol 2000; 10:161-164. (Pubitemid 30115749)
29. Thomas MJ, Sjaastad I, Andersen K, Helm PJ, Wasserstrom JA, Sejersted OM, et al. Localization and function of the Na\+/Ca2\+-exchanger in normal and detubulated rat cardiomyocytes. J Mol Cell Cardiol 2003; 35:1325-1337. (Pubitemid 37330090)
30. Gottlieb RA, Gruol DL, Zhu JY, Engler RL. Preconditioning rabbit cardiomyocytes: role of pH, vacuolar proton ATPase, and apoptosis. J Clin Invest 1996; 97:2391-2398.
31. Karwatowska-Prokopczuk E, Nordberg JA, Li HL, Engler RL, Gottlieb RA. Effect of vacuolar proton ATPase on pHi, Ca2\+, and apoptosis in neonatal cardiomyocytes during metabolic inhibition/recovery. Circ Res 1998; 82:1139-1144. (Pubitemid 28311122)
32. Long X, Crow MT, Sollott SJ, O'Neill L, Menees DS, de Lourdes Hipolito M, et al. Enhanced expression of p53 and apoptosis induced by blockade of the vacuolar proton ATPase in cardiomyocytes. J Clin Invest 1998; 101:1453-1461. (Pubitemid 28145263)
33. Lagadic-Gossmann D, Buckler KJ, Vaughan-Jones RD. Role of bicarbonate in pH recovery from intracellular acidosis in the guinea-pig ventricular myocyte. J Physiol 1992; 458:361-384. (Pubitemid 23024598)
34. Lazdunski M, Frelin C, Vigne P. The sodium/hydrogen exchange system in cardiac cells: its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. J Mol Cell Cardiol 1985; 17:1029-1042. (Pubitemid 16200867)
35. Vaughan-Jones RD. An investigation of chloride-bicarbonate exchange in the sheep cardiac Purkinje fibre. J Physiol 1986; 379:377-406. (Pubitemid 17175925)
36. Kinouchi K, Ichihara A, Sano M, Sun-Wada GH, Wada Y, Kurauchi-Mito A, et al. The (pro)renin receptor/ATP6AP2 is essential for vacuolar H\+- ATPase assembly in murine cardiomyocytes. Circ Res 2010; 107:30-34.
37. Watkins SJ, Borthwick GM, Arthur HM. The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro. In Vitro Cell Dev Biol Anim 2010 [Epub ahead of print].
38. Toblli JE, Cao G, DeRosa G, Di Gennaro F, Forcada P. Angiotensinconverting enzyme inhibition and angiogenesis in myocardium of obese Zucker rats. Am J Hypertens 2004; 17:E172-E180.
39. Sabino B, Lessa MA, Nascimento AR, Rodrigues CA, Henriques MG, Garzoni LR, et al. Effects of antihypertensive drugs on capillary rarefaction in spontaneously hypertensive rats: intravital microscopy and histologic analysis. J Cardiovasc Pharmacol 2008; 51:402-409. (Pubitemid 351572240)
40. Feldman DL, Jin L, Xuan H, Contrepas A, Zhou Y, Webb RL, et al. Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats. Hypertension 2008; 52:130-136.
41. Pilz B, Shagdarsuren E, Wellner M, Fiebeler A, Dechend R, Gratze P, et al. Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats. Hypertension 2005; 46:569-576. (Pubitemid 41376839)
42. Westermann D, Riad A, Lettau O, Roks A, Savvatis K, Becher PM, et al. Renin inhibition improves cardiac function and remodeling after myocardial infarction independent of blood pressure. Hypertension 2008; 52:1068-1075.
43. Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 2004; 25:543-567. (Pubitemid 39096070)
44. Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil JG. Diastolic dysfunction in normotensive men with well controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care 2001; 24:5-10. (Pubitemid 32104211)
45. Schannwell CM, Schneppenheim M, Perings S, Plehn G, Strauer BE. Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. Cardiology 2002; 98:33-39. (Pubitemid 35375651)
46. Tschope C, Walther T, Koniger J, Spillmann F, Westermann D, Escher F, et al. Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene. FASEB J 2004; 18:828-835. (Pubitemid 38544501)
47. Spinale FG. Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circ Res 2002; 90:520-530. (Pubitemid 34640901)
48. Cingolani OH, Yang XP, Liu YH, Villanueva M, Rhaleb NE, Carretero OA. Reduction of cardiac fibrosis decreases systolic performance without affecting diastolic function in hypertensive rats. Hypertension 2004; 43:1067-1073. (Pubitemid 38579915)
49. Whaley-Connell A, Habibi J, Cooper SA, Demarco VG, Hayden MR, Stump CS, et al. Effect of renin inhibition and AT1R blockade on myocardial remodeling in the transgenic Ren2 rat. Am J Physiol Endocrinol Metab 2008; 295:E103-109.